1. AB0486 The Complete Response in Patients with Lupus Nephritis Treated with Mycophenolate Mofetil (MMF) as Their First Line Therapy. (10th June 2014) Authors: Timlin, H.; Magder, L.; Petri, M. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 968 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0621 The timing of urinary protein creatinine ratio normalization in patients with ln treated with mycophenolate mofetil (MMF) as their first line therapy. (23rd January 2014) Authors: Timlin, H.; Fang, H.; Magder, L.; Petri, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 674 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0163 ANTIPHOSPHOLIPID PATTERNS PREDICT THE RISK OF THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS. (2nd June 2020) Authors: Demir, S.; LI, J.; Magder, L.; Petri, M. A. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0363 Positive remodelling index and low attenuation non-calcified coronary plaques: markers of vulnerable coronary plaques in systemic lupus?. (12th June 2018) Authors: Stojan, G.; Magder, L.; Petri, M. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 716 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0405 Prednisone Increases Both Arterial and Venous Thrombosis in SLE. (9th June 2015) Authors: Hickman, K.; Magder, L.; Petri, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0406 Small LDL-P Increases with Increased Disease Activity in SLE. (9th June 2015) Authors: Durcan, L.J.; Winegar, D.; Connelly, M.A.; Otvos, J.; Magder, L.; Petri, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0423 Impact of Disease Activity on Organ Damage Risk Over Time in Systemic Lupus Erythematosus – The Hopkins Lupus Cohort. (9th June 2015) Authors: Burge, R.T.; Al Sawah, S.; Zhang, X.; Wang, Y.; Magder, L.; Petri, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0431 Venous and Arterial Thrombosis in Sle: Differences in Natural History. (10th June 2014) Authors: Hickman, K.; Magder, L.; Petri, M. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OP0093 The Natural History of Thrombotic Events in Systemic Lupus Erythematosus and Associated Risk Factors. (9th June 2015) Authors: Hickman, K.; Magder, L.; Petri, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0187 Hydroxychloroquine Blood Levels in Sle: Clarifying Dosing Controversies and Improving Adherence. (9th June 2015) Authors: Durcan, L.J.; Clarke, W.A.; Magder, L.; Petri, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗